Tuberculosis

Cited by (1,000)

Items 101–200 of 1,000

  1. Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches
    Guilherme Bartolomeu-Gonçalves, Joyce Marinho de Souza, Bruna Terci Fernandes, Laís Fernanda de Almeida Spoladori, Guilherme Ferreira Correia, Isabela Madeira de Castro, Paulo Henrique Guilherme Borges, Gislaine Silva-Rodrigues, Eliandro Reis Tavares, Lucy Megumi Yamauchi et al. · 2024 · Diseases
  2. Microparticles prepared with 50–190 kDa chitosan as promising non-toxic carriers for pulmonary delivery of isoniazid
    Paula Martins de Oliveira, Breno N. Matos, Priscilla Aparecida Tártari Pereira, Taís Gratieri, Lúcia Helena Faccioli, Marcílio Cunha‐Filho, Guilherme M. Gelfuso · 2017 · Carbohydrate Polymers
  3. Label-Free and Real-Time Detection of Tuberculosis in Human Urine Samples Using a Nanophotonic Point-of-Care Platform
    Patricia Ramirez‐Priego, Daan Martens, Ayssar A. Elamin, Pieterjan Soetaert, W. Van Roy, Rita Vos, Birgit Anton, Ronny Bockstaele, Holger Becker, Mahavir Singh et al. · 2018 · ACS Sensors
  4. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection
    Gemma O’Connor, Nitya Krishnan, Aidan Fagan-Murphy, Joseph P. Cassidy, Seónadh M. O’Leary, Brian D. Robertson, Joseph Keane, Mary P. O’Sullivan, Sally‐Ann Cryan · 2018 · European Journal of Pharmaceutics and Biopharmaceutics
  5. Classical CD4 T cells as the cornerstone of antimycobacterial immunity
    Jeffrey Morgan, Kaylin Muskat, Rashmi Tippalagama, Alessandro Sette, Julie G. Burel, Cecilia S. Lindestam Arlehamn · 2021 · Immunological Reviews
  6. Tuberculosis and risk of cancer: A systematic review and meta-analysis
    Pauline Luczynski, Philip Poulin, Kamila Romanowski, James Cameron Johnston · 2022 · PLoS ONE
  7. Virulence Factors of Mycobacterium tuberculosis as Modulators of Cell Death Mechanisms
    Lucero A. Ramón‐Luing, Yadira Palacios, Andy Ruíz, Norma Angélica Téllez-Navarrete, Leslie Chávez‐Galán · 2023 · Pathogens
  8. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination
    Mariateresa Coppola, Tom H. M. Ottenhoff · 2018 · Seminars in Immunology
  9. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis
    Nathella Pavan Kumar, Kadar Moideen, Arul Nancy, Vijay Viswanathan, Basavaradhya S. Shruthi, Shanmugam Sivakumar, Mohan Natarajan, Hardy Kornfeld, Subash Babu · 2019 · Scientific Reports
  10. Latent Tuberculosis: Two Centuries of Confusion.
    Marcel A. Behr, Eva Kaufmann, Jacalyn M. Duffin, Paul H. Edelstein, Lalita Ramakrishnan · 2021 · Apollo (University of Cambridge)
  11. Interaction of Mycobacteria With Host Cell Inflammasomes
    Shivangi Rastogi, Volker Briken · 2022 · Frontiers in Immunology
  12. mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
    Laura Matarazzo, Paulo J. G. Bettencourt · 2023 · Frontiers in Immunology
  13. Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis
    Michael Reiche, Digby Francis Warner, Valerie Mizrahi · 2017 · Frontiers in Molecular Biosciences
  14. Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals
    Rydvikha Govender, Susanna Abrahmsén‐Alami, Anette Larsson, Staffan Folestad · 2020 · European Journal of Pharmaceutics and Biopharmaceutics
  15. In-host population dynamics of Mycobacterium tuberculosis complex during active disease
    Roger Vargas, Luca Freschi, Maximillian G. Marin, L. Elaine Epperson, Melissa Laird Smith, Irina A. Oussenko, David Durbin, Michael Strong, Max Salfinger, Maha Reda Farhat · 2021 · eLife
  16. The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection
    Rasoul Mirzaei, Sajad Babakhani, Parisa Ajorloo, Razieh Heidari Ahmadi, Seyed Reza Hosseini‐Fard, Hossein Keyvani, Yaghoub Ahmadyousefi, Ali Teimoori, Farhad Zamani, Sajad Karampoor et al. · 2021 · Molecular Medicine
  17. Microbiota and Tuberculosis: A Potential Role of Probiotics, and Postbiotics
    Yue Liu, Jiaqi Wang, Changxin Wu · 2021 · Frontiers in Nutrition
  18. A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active Tuberculosis
    Vera Marie Kroesen, Paula Rodríguez‐Martínez, Eric García, Yaiza Rosales, Jorge Dı́az, Montse Martín-Céspedes, Gustavo Tapia, Maria‐Rosa Sarrias, Père-Joan Cardona, Cristina Vilaplana · 2018 · Frontiers in Immunology
  19. The Impact of Alcohol Use Disorder on Tuberculosis: A Review of the Epidemiology and Potential Immunologic Mechanisms
    Gregory W. Wigger, Tara C. Bouton, Karen Rita Jacobson, Sara C. Auld, Samantha M. Yeligar, Bashar S. Staitieh · 2022 · Frontiers in Immunology
  20. T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation
    Munyaradzi Musvosvi, Darragh Duffy, Elizabeth Filander, Hadn Africa, Simbarashe Mabwe, Lungisa Jaxa, Nicole Bilek, Alba Llibre, Vincent Rouilly, Mark Hatherill et al. · 2018 · European Respiratory Journal
  21. Systematic Review and Meta-Analysis of Sex Differences in Social Contact Patterns and Implications for Tuberculosis Transmission and Control
    Katherine Chisholm Horton, Anne L. Hoey, Guillaume Béraud, Elizabeth Lucy Corbett, Richard Guy White · 2020 · Emerging infectious diseases
  22. Evolution of tuberculosis diagnostics: From molecular strategies to nanodiagnostics
    Srestha Mukherjee, Summaya Perveen, Anjali Negi, Rashmi Sharma · 2023 · Tuberculosis
  23. Mycobacterium tuberculosis Metabolism
    Gabriel T. Mashabela, Timothy J. de Wet, Digby Francis Warner · 2019 · Microbiology Spectrum
  24. Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis
    Phuong Chi Nguyen, Vincent Delorme, Anaïs Bénarouche, Benjamin P. Martin, Rishi R. Paudel, Giri Raj Gnawali, Abdeldjalil Madani, Rémy Puppo, Valérie Landry, Laurent Kremer et al. · 2017 · Scientific Reports
  25. Tuberculosis in Children
    Peter J. Holmberg, Zelalem Temesgen, Ritu Banerjee · 2019 · Pediatrics in Review
  26. Pyroptosis in host defence against bacterial infection
    Dominik Brokatzky, Serge Mostowy · 2022 · Disease Models & Mechanisms
  27. Targeting isocitrate lyase for the treatment of latent tuberculosis
    Ram Prasad Bhusal, Ghader Bashiri, Brooke X. C. Kwai, Jonathan Sperry, Ivanhoe K. H. Leung · 2017 · Drug Discovery Today
  28. Spatio-temporal variation in tuberculosis incidence and risk factors for the disease in a region of unbalanced socio-economic development
    Li Wang, Chengdong Xu, Maogui Hu, Jiajun Qiao, Wei Chen, Tao Li, Songbo Qian, Mingtao Yan · 2021 · BMC Public Health
  29. Tuberculosis pathophysiology and anti-VEGF intervention
    David P. Maison · 2022 · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
  30. Tuberculosis caused by Mycobacterium africanum: Knowns and unknowns
    Marta Silva, Baltazar Cá, Nuno Sampaio Osório, Pedro Rodrigues, Ana Raquel Maceiras, Margarida Saraiva · 2022 · PLoS Pathogens
  31. Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
    Byung Woo Jhun, Won‐Jung Koh · 2019 · Tuberculosis & respiratory diseases
  32. The Human Microbiota, Infectious Disease, and Global Health: Challenges and Opportunities
    Abraham J. Waldman, Emily P. Balskus · 2017 · ACS Infectious Diseases
  33. High dose dry powder inhalers to overcome the challenges of tuberculosis treatment
    Mohammad A. M. Momin, Ian G. Tucker, Shyamal C. Das · 2018 · International Journal of Pharmaceutics
  34. Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study
    Caian L. Vinhaes, Deivide Oliveira-de-Souza, Paulo S. Silveira-Mattos, Betânia M. F. Nogueira, Ruiru Shi, Wang Wei, Xing Yuan, Guolong Zhang, Ying Cai, Clifton E. Barry et al. · 2019 · Cytokine
  35. Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents
    Ana Flávia Borsoi, Josiane Delgado Paz, Bruno Lopes Abbadi, Fernanda Souza Macchi, Nathalia Denise de Moura Sperotto, Kenia Pissinate, Raoní Scheibler Rambo, Alessandro Silva Ramos, Diana Machado, Miguel Viveiros et al. · 2020 · European Journal of Medicinal Chemistry
  36. Glyphosate: Hepatotoxicity, Nephrotoxicity, Hemotoxicity, Carcinogenicity, and Clinical Cases of Endocrine, Reproductive, Cardiovascular, and Pulmonary System Intoxication
    Jarosław Mazuryk, Katarzyna Klepacka, Wlodzinierz Kutner, P. Sharma · 2024 · ACS Pharmacology & Translational Science
  37. Detection of tuberculosis in patients with the use of portable SPR device
    Maciej Trzaskowski, Agnieszka Napiórkowska, EWA M. AUGUSTYNOWICZ-KOPEĆ, Tomasz Ciach · 2018 · Sensors and Actuators B Chemical
  38. Beyond Killing Mycobacterium tuberculosis: Disease Tolerance
    Maziar Divangahi, Nargis Khan, Eva Kaufmann · 2018 · Frontiers in Immunology
  39. The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
    Tandeka Magcwebeba, Anca Dorhoi, Nelita du Plessis · 2019 · Frontiers in Immunology
  40. Diagnostic Accuracy of a Novel and Rapid Lipoarabinomannan Test for Diagnosing Tuberculosis Among People With Human Immunodeficiency Virus
    Stephanie Bjerrum, Tobias Broger, Rita Székely, Satoshi Mitarai, Japheth A. Opintan, Ernest Kenu, Margaret Yaa Lartey, Kennedy Kwasi Addo, Kinuyo Chikamatsu, Aurélien Macé et al. · 2019 · Open Forum Infectious Diseases
  41. ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease
    Roger M. Feakins, Joana Torres, Paula Borralho, Johan M. Burisch, Tiago Cúrdia Gonçalves, Lissy de Ridder, Ann L. C. Driessen, Triana Lobatón, Luis A. Menchen, Aart Mookhoek et al. · 2021 · Journal of Crohn s and Colitis
  42. Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?
    Lehlogonolo N. F. Maphalle, Bozena B. Michniak‐Kohn, Modupe Olufunmilayo Ogunrombi, Oluwatoyin A. Adeleke · 2022 · Children
  43. Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal
    Battini Swapna, M. K. Chaitanya Mannava, Ashwini Kumar Nangia · 2018 · Journal of Pharmaceutical Sciences
  44. Potential Diagnostic Properties of Chest Ultrasound in Thoracic Tuberculosis—A Systematic Review
    Francesco Di Gennaro, Luigi Pisani, Nicola Veronese, Damiano Pizzol, Valeria Lippolis, Annalisa Saracino, Laura Monno, Michaëla A. M. Huson, Roberto Copetti, Giovanni Putoto et al. · 2018 · International Journal of Environmental Research and Public Health
  45. Pyrazinamide drug resistance in RpsA mutant (∆438A) of Mycobacterium tuberculosis : Dynamics of essential motions and free‐energy landscape analysis
    Aditi Puri Singh, Pallavi Somvanshi, Abhinav Grover · 2018 · Journal of Cellular Biochemistry
  46. How Well Do Routine Molecular Diagnostics Detect Rifampin Heteroresistance in Mycobacterium tuberculosis?
    Kamela Charmaine S. Ng, Philip Supply, Frank G. J. Cobelens, Cyril Gaudin, Julian González-Martín, Bouke Catherine de Jong, Leen Rigouts · 2019 · Journal of Clinical Microbiology
  47. Vaccine Development Against Tuberculosis Over the Last 140 Years: Failure as Part of Success
    Stefan H. E. Kaufmann · 2021 · Frontiers in Microbiology
  48. Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review
    Jacob Bigio, Mikashmi Kohli, Joel Shyam Klinton, Emily Lai-Ho MacLean, Genevieve C. Gore, Peter M. Small, Morten Rühwald, Stefan Fabian Weber, Saurabh Kumar Jha, Madhukar Pai · 2021 · PLoS ONE
  49. Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs
    Juan Manuel Cubillos-Angulo, Betânia M. F. Nogueira, María B. Arriaga, Beatriz Barreto‐Duarte, Mariana Araújo‐Pereira, Catarina Dinis Fernandes, Caian L. Vinhaes, Klauss Villalva-Serra, Vanessa M. Nunes, João Pedro Miguez-Pinto et al. · 2022 · Frontiers in Medicine
  50. Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis : Computational Analysis of Physicochemical and ADMET Properties
    Patrícia S. M. Amado, Christopher M. Woodley, Maria L. S. Cristiano, Paul M. O’Neill · 2022 · ACS Omega
  51. Tuberculosis innovations mean little if they cannot save lives
    Madhukar Pai, Jennifer Joan Furin · 2017 · eLife
  52. Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds
    Guilherme Fernandes, Chung Man Chin, Jean Leandro dos Santos · 2017 · Pharmaceuticals
  53. Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study
    Arto Yuwono Soeroto, Bony Wiem Lestari, Prayudi Santoso, Lidya Chaidir, Basti Andriyoko, Bachti Alisjahbana, Reinout van Crevel, Philip C. Hill · 2019 · PLoS ONE
  54. MiR‐21‐5p regulates mycobacterial survival and inflammatory responses by targeting Bcl‐2 and TLR4 in Mycobacterium tuberculosis‐infected macrophages
    Zhonghua Zhao, Jinzhu Hao, Xia Li, Yanfang Chen, Xiaoyan Qi · 2019 · FEBS Letters
  55. Detection and Quantification of HspX Antigen in Sputum Samples Using Plasmonic Biosensing: Toward a Real Point-of-Care (POC) for Tuberculosis Diagnosis
    E. Cristina Peláez-Gutierrez, M.‐Carmen Estévez, Alvaro Monguí, M-Carmen Menéndez, Carlos Toro, Oscar Herrera, Jaime Robledo, Maria J. García, Patricia Del Portillo, Laura M. Lechuga · 2020 · ACS Infectious Diseases
  56. Systemic Inflammation Associated with Immune Reconstitution Inflammatory Syndrome in Persons Living with HIV
    Caian L. Vinhaes, Mariana Araújo‐Pereira, Rafael Tibúrcio, Juan Manuel Cubillos-Angulo, Fernanda O. Demitto, Kevan Akrami, Bruno B. Andrade · 2021 · Life
  57. Diagnostic Accuracy of the Artificial Intelligence Methods in Medical Imaging for Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis
    Yuejuan Zhan, Yuqi Wang, Wendi Zhang, Binwu Ying, Chengdi Wang · 2022 · Journal of Clinical Medicine
  58. Tuberculosis—a World Health Organization Perspective
    Giovanni Sotgiu, Giorgia Sulis, Alberto Matteelli · 2017 · Microbiology Spectrum
  59. Genetic Resistance to Mycobacterium tuberculosis Infection and Disease
    Marlo Möller, Craig John Kinnear, Marianna Orlova, Elouise E. Kroon, Paul D. van Helden, Erwin Schurr, Eileen Garner Hoal · 2018 · Frontiers in Immunology
  60. Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed Therapies
    Pobitra Borah, Pran Kishore Deb, Katharigatta Narayanaswamy Venugopala, Nizar A. Al‐Shar’i, Vinayak Singh, Satyendra Deka, Amavya Srivastava, Vinod K. Tiwari, Raghu Prasad Mailavaram · 2020 · Current Topics in Medicinal Chemistry
  61. Differential Recognition of Mycobacterium tuberculosis –Specific Epitopes as a Function of Tuberculosis Disease History
    Thomas J. Scriba, Chelsea Carpenter, Sebastian Carrasco Pro, John Sidney, Munyaradzi Musvosvi, Virginie Rozot, Grégory Seumois, Sandy Lisette Rosales, Pandurangan Vijayanand, Delia Goletti et al. · 2017 · American Journal of Respiratory and Critical Care Medicine
  62. New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development
    Masayuki Igarashi, Yoshimasa Ishizaki, Yoshiaki Takahashi · 2017 · The Journal of Antibiotics
  63. A Bayesian Approach to Understanding Sex Differences in Tuberculosis Disease Burden
    Katherine Chisholm Horton, Tom Sumner, Rein M G J Houben, Elizabeth Lucy Corbett, Richard Guy White · 2018 · American Journal of Epidemiology
  64. Structural Prediction and Mutational Analysis of Rv3906c Gene of Mycobacterium tuberculosis H37Rv to Determine Its Essentiality in Survival
    Md Amjad Beg, Shivangi Shivangi, Sonu Chand Thakur, Laxman S. Meena · 2018 · Advances in Bioinformatics
  65. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients
    Mi Ra Ryu, Min‐Seung Park, Eun Hye Cho, Chul Won Jung, Kihyun Kım, Seok Jin Kim, Ha Young Oh, Wooseong Huh, Hye Ryoun Jang, Won‐Jung Koh et al. · 2018 · Journal of Clinical Microbiology
  66. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection
    Leonardo Silva de Araujo, Marcelo Ribeiro Alves, Thyago Leal-Calvo, Janaína Leung, Verónica Durán, Mohamed Samir, Steven Roger Talbot, Aravind Tallam, Fernanda Carvalho de Queiroz Mello, Robert Geffers et al. · 2019 · mBio
  67. Advances in the design of combination therapies for the treatment of tuberculosis
    Jonah Larkins‐Ford, Bree B. Aldridge · 2022 · Expert Opinion on Drug Discovery
  68. Autophagy promotes efficient T cell responses to restrict high-dose Mycobacterium tuberculosis infection in mice
    Siwei Feng, Michael E. McNehlan, Rachel L. Kinsella, Chanchal Sur Chowdhury, Sthefany M. Chavez, Sumanta Kumar Naik, Samuel R. McKee, Jacob A. Van Winkle, Neha Dubey, Amanda N. Samuels et al. · 2024 · Nature Microbiology
  69. Horizontal acquisition of a hypoxia-responsive molybdenum cofactor biosynthesis pathway contributed to Mycobacterium tuberculosis pathoadaptation
    Florence Levillain, Yannick Poquet, Ludovic Mallet, Serge Mazères, Michaël Marceau, Roland Brosch, Franz‐Christoph Bange, Philip Supply, Axel Magalon, Olivier Neyrolles · 2017 · PLoS Pathogens
  70. Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of Tuberculosis
    Julie G. Burel, Mariana Babor, Mikhail Pomaznoy, Cecilia S. Lindestam Arlehamn, Nabeela A. Khan, Alessandro Sette, Bjoern Peters · 2019 · Frontiers in Immunology
  71. Comparative genomics of Mycobacterium africanum Lineage 5 and Lineage 6 from Ghana suggests distinct ecological niches
    I. Otchere, Mireia Coscollá, L. Sánchez-Busó, A. Asante-Poku, D. Brites, C. Loiseau, C. Meehan, S. Osei-Wusu, A. Forson, Clement Laryea et al. · 2018 · Scientific Reports
  72. Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro–American genetic background confers optimal vaccine potential
    Irene Pérez, Santiago Uranga, Fadel Sayes, Wafa Frigui, Sofía Samper, Ainhoa Arbués, Nacho Aguiló, Roland Brosch, Carlos Martı́n, Jesús Gonzalo‐Asensio · 2020 · EBioMedicine
  73. Aerosol pulmonary immune engineering
    Emma R. Sudduth, Michael Trautmann-Rodriguez, Nicole A. Gill, Kartik Bomb, Catherine A. Fromen · 2023 · Advanced Drug Delivery Reviews
  74. Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice
    Fan Yang, Alireza Labani‐Motlagh, José Alejandro Bohórquez, Jôsimar Dornelas Moreira, Danish Ansari, Sahil Patel, Fabrizio Spagnolo, Jon Florence, Abhinav Vankayalapati, Tsuyoshi Sakai et al. · 2024 · Communications Biology
  75. Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics
    Alvin Kuo Jing Teo, Emily Lai-Ho MacLean, Greg James Fox · 2024 · European Respiratory Review
  76. Real-Time Sequencing of Mycobacterium tuberculosis: Are We There Yet?
    Robyn S. Lee, Madhukar Pai · 2017 · Journal of Clinical Microbiology
  77. Polyester as Antigen Carrier toward Particulate Vaccines
    Majela González-Miró, Shuxiong Chen, Zennia Jean Gonzaga, Benjamin J. Evert, David Wibowo, Bernd H. A. Rehm · 2019 · Biomacromolecules
  78. An RNA-seq Based Machine Learning Approach Identifies Latent Tuberculosis Patients With an Active Tuberculosis Profile
    Olivia Estévez, Luis Anibarro, Elina Garet, Ángeles Pallarés, Laura Barcia, Laura Calviño, Cremildo Maueia, Tufária Mussá, Florentino Fdez‐Riverola, Daniel Glez‐Peña et al. · 2020 · Frontiers in Immunology
  79. Antimicrobial Peptides as Potential Anti-Tubercular Leads: A Concise Review
    Gabriel S. Oliveira, Raquel P. Costa, Paula A. C. Gomes, Maria Salomé Gomes, Tânia Silva, Cátia A. S. Teixeira · 2021 · Pharmaceuticals
  80. Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort
    Kristina L. Bajema, Ingrid Valerie Bassett, Sharon M. Coleman, Douglas Ross, Kenneth A. Freedberg, Anna Wald, Paul K. Drain · 2019 · BMC Infectious Diseases
  81. Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility
    Phillip Ssekamatte, Obondo James Sande, Reinout van Crevel, Irene Andia Biraro · 2023 · Frontiers in Immunology
  82. Plant antibacterials: The challenges and opportunities
    Tomayo I. Berida, Yemi Adekola Adekunle, Hannah Odunola Dada-Adegbola, Ayoub Kdimy, Sudeshna Roy, Satyajit Dey Sarker · 2024 · Heliyon
  83. Unsupervised CT Lung Image Segmentation of a Mycobacterium Tuberculosis Infection Model
    Pedro M. Gordaliza, Arrate Muñoz‐Barrutia, Mónica Abella, Manuel Desco, Sally A. Sharpe, Juan José Vaquero · 2018 · Scientific Reports
  84. The role of super-spreading events in Mycobacterium tuberculosis transmission: evidence from contact tracing
    Yayehirad Alemu Melsew, Manoj Gambhir, Allen C. Cheng, Emma Sue McBryde, Justin Timothy Denholm, Ee Laine Tay, James McCracken Trauer · 2019 · BMC Infectious Diseases
  85. Tracking down the White Plague: The skeletal evidence of tuberculous meningitis in the Robert J. Terry Anatomical Skeletal Collection
    Olga Spekker, David R. Hunt, László Paja, Erika Molnár, György Pálfi, Michael Schultz · 2020 · PLoS ONE
  86. Natural-Product-Based Solutions for Tropical Infectious Diseases
    Oyelola Adegboye, Matthew A. Field, Andreas Kupz, Saparna Pai, Dileep Sharma, Michael J. Smout, Phurpa Wangchuk, Yide Wong, Claire Loiseau · 2021 · Clinical Microbiology Reviews
  87. Antitubercular Bis-Substituted Cyclam Derivatives: Structure–Activity Relationships and in Vivo Studies
    Malcolm P. Spain, Joseph K.-H. Wong, Gayathri Nagalingam, James M. Batten, Elinor Hortle, Stefan H. Oehlers, Xiao Fan Jiang, Hasini E. Murage, Jack T. Orford, Patrick Crisologo et al. · 2018 · Journal of Medicinal Chemistry
  88. Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children
    Michela Sali, Danilo Buonsenso, Pamela D’Alfonso, Flavio De Maio, Manuela Ceccarelli, Basem Battah, Ivana Palucci, Teresa Chiacchio, Delia Goletti, Maurizio Sanguinetti et al. · 2018 · Journal of Infection
  89. Characterisation of genes differentially expressed in macrophages by virulent and attenuated Mycobacterium tuberculosis through RNA-Seq analysis
    Junghwan Lee, Sung‐Gwon Lee, Kee Kwang Kim, Yun-Ji Lim, Ji-Ae Choi, Soo‐Na Cho, Chungoo Park, Chang‐Hwa Song · 2019 · Scientific Reports
  90. Cross-validation of existing signatures and derivation of a novel 29-gene transcriptomic signature predictive of progression to TB in a Brazilian cohort of household contacts of pulmonary TB
    Samantha Leong, Yue Zhao, Rodrigo Ribeiro‐Rodrigues, Edward C. Jones‐López, Carlos Acuña-Villaorduña, Patrícia Marques Rodrigues, Moisés Palaci, David Alland, Reynaldo Dietze, Jerrold J. Ellner et al. · 2020 · Tuberculosis
  91. Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring
    Rim Bayaa, Mame Diarra Ndiaye, Carole Chedid, Eka Kokhreidze, Nestani Tukvadze, Sayera Banu, Mohammad Khaja Mafij Uddin, Samanta Biswas, Rumana Nasrin, Paulo PR. Ranaivomanana et al. · 2021 · Scientific Reports
  92. Neutrophils Contribute to Severity of Tuberculosis Pathology and Recovery From Lung Damage Pre- and Posttreatment
    Caleb Nwongbouwoh Muefong, Olumuyiwa Owolabi, Simon A. Donkor, Salome Charalambous, Abhishek Bakuli, Andrea Rachow, Christof Geldmacher, Jayne S. Sutherland · 2021 · Clinical Infectious Diseases
  93. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial
    Paulo César Pereira dos Santos, Nicole L. Messina, Roberto Dias de Oliveira, Patrícia Vieira da Silva, Marco Antonio Moreira Puga, Margareth Pretti Dalcolmo, Glauce dos Santos, Marcus Lacerda, Bruno Araújo Jardim, Fernando Fonseca de Almeida e Val et al. · 2024 · The Lancet Infectious Diseases
  94. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives
    Christopher M. Goins, Steven Dajnowicz, Sandeep Thanna, Steven J. Sucheck, Jerry M. Parks, Donald R. Ronning · 2017 · ACS Infectious Diseases
  95. Pathogenesis and Animal Models of Post-Primary (Bronchogenic) Tuberculosis, A Review
    Robert Lee Hunter, Jeffrey K. Actor, Shen‐An Hwang, Arshad Khan, Michael E. Urbanowski, Deepak Kaushal, Chinnaswamy Jagannath · 2018 · Pathogens
  96. How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriers
    Lena Faust, Morten Rühwald, Samuel G. Schumacher, Madhukar Pai · 2020 · Health Science Reports
  97. Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice
    Cameron C. Hanna, Anneliese S. Ashhurst, Diana H. Quan, Joshua W. C. Maxwell, Warwick J. Britton, Richard J. Payne · 2021 · Proceedings of the National Academy of Sciences
  98. Genitourinary Tuberculosis: A Comprehensive Review of a Neglected Manifestation in Low-Endemic Countries
    Guglielmo Mantica, Francesca Ambrosini, Niccolò Riccardi, Enrico Vecchio, Lorenzo Rigatti, Aldo Franco De Rose, André van der Merwe, Carlo Terrone, Riccardo Bartoletti, Gernot Bonkat · 2021 · Antibiotics
  99. Modifications, biological origin and antibacterial activity of naphthalenoid ansamycins
    Natalia Skrzypczak, Piotr Przybylski · 2022 · Natural Product Reports
  100. Epidemiology of tuberculous lymphadenitis in Africa: A systematic review and meta-analysis
    Daniel Shitu Mekonnen, Awoke Derbie, Andargachew Abeje, Abebe Shumet, Endalkachew Nibret, Fantahun Biadglegne, Abaineh Munshae, Kidist Bobosha, Liya Wassie, Stefan Berg et al. · 2019 · PLoS ONE